Continuing Professional Development

Continuing Professional Development

Context: A CMO previously focussing on fine chemicals and monoclonal antibody manufacture were planning to start manufacturing regenerative medicine products, such as cell, gene and immunotherapies. Given the fundamentally different manufacturing processes, staff required training in the new area.

Solution: IPAV provided a CPD accredited training programme on gene therapy, cell therapy immunotherapy and tissue engineering, in comparison to more traditional biologics manufacture. To ensure breadth and depth of essential knowledge, the training content comprised basic science, bioprocessing and market landscaping. Training was delivered via in person sessions, presentation slides and training manuals.

Outcome: The CMO experienced quicker process time and low numbers of standard operating procedure breaches. Staff satisfaction was high, employees felt well equipped to undertake new process manufacture, and they were confident in their understanding of the field more broadly.

Related Projects